Because of these routine self-medication regimens, this study also explored possible influences of statins and RAASI (angiotensin-converting enzyme inhibitors, angiotensin-II-receptor antagonists, and spironolactone) on COVID-19 patients regarding clinical and routine laboratory testing results. This evidence concerns the gene ACE and COVID-19.